Ivakaftor (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Ivakaftor" in Serbian language version.
refsWebsite
Global rank
Serbian rank
406th place
1,286th place
1st place
1st place
doi.org
- Jones AM, Helm JM (2009). „Emerging treatments in cystic fibrosis”. Drugs. 69 (14): 1903—10. PMID 19747007. doi:10.2165/11318500-000000000-00000.
- Van Goor F, Hadida S, Grootenhuis PD, Burton B, Cao D, Neuberger T, Turnbull A, Singh A, Joubran J (2009). „Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770”. Proceedings of the National Academy of Sciences of the United States of America. 106 (44): 18825—30. PMC 2773991
. PMID 19846789. doi:10.1073/pnas.0904709106. - Sloane PA, Rowe SM (2010). „Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis”. Current opinion in pulmonary medicine. 16 (6): 591—7. PMID 20829696. doi:10.1097/MCP.0b013e32833f1d00.
- Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW (2010). „Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation”. The New England journal of medicine. 363 (21): 1991—2003. PMID 21083385. doi:10.1056/NEJMoa0909825.
go.com
abcnews.go.com
- Drug Approved to Treat Cystic Fibrosis' Root Cause Архивирано на сајту Wayback Machine (4. фебруар 2012) By MATTHEW PERRONE, AP Health Writer, ABC News, January 31, 2012
nih.gov
ncbi.nlm.nih.gov
- Jones AM, Helm JM (2009). „Emerging treatments in cystic fibrosis”. Drugs. 69 (14): 1903—10. PMID 19747007. doi:10.2165/11318500-000000000-00000.
- Van Goor F, Hadida S, Grootenhuis PD, Burton B, Cao D, Neuberger T, Turnbull A, Singh A, Joubran J (2009). „Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770”. Proceedings of the National Academy of Sciences of the United States of America. 106 (44): 18825—30. PMC 2773991 . PMID 19846789. doi:10.1073/pnas.0904709106.
- Sloane PA, Rowe SM (2010). „Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis”. Current opinion in pulmonary medicine. 16 (6): 591—7. PMID 20829696. doi:10.1097/MCP.0b013e32833f1d00.
- Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW (2010). „Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation”. The New England journal of medicine. 363 (21): 1991—2003. PMID 21083385. doi:10.1056/NEJMoa0909825.
prnewswire.com
web.archive.org
- Drug Approved to Treat Cystic Fibrosis' Root Cause Архивирано на сајту Wayback Machine (4. фебруар 2012) By MATTHEW PERRONE, AP Health Writer, ABC News, January 31, 2012